"Engineering T Cells against Cancer Vulnerabilities" - Prof. Dr. med. Sebastian Kobold, Ludwig-Maximilians-Universität München
Einladung zur 14. CCCI Lecture über "Engineering T Cells against Cancer Vulnerabilities" am 01.07.2025 um 16:00 Uhr im MZA Hörsaal.
Prof. Dr. med. Sebastian Kobold is a physician-scientist and Professor of Experimental Immuno-Oncology at Ludwig-Maximilians-Universität München. He completed his medical degree at Saarland University and earned a PhD from the University of Oxford, focusing on immunological research. His pioneering work in immuno-oncology has been published in prestigious Journals like Nature and Immunity and was recognized with numerous awards, including the ERC Starting Grant and the Georges-Köhler-Award.
zurück zur Übersicht